Learn, Analyse & Invest
only with

+91

Download Orca

To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Syngene International Ltd.

Syngene Internation.

₹ 0.00

0.00 (0.00)%

NSE

BSE

Business Support

Small-cap - With a market cap of ₹252.02 Cr.

EX-Date	Purpose
20 07 2021	Quarterly Results
20 10 2021	Quarterly Results
19 01 2022	Quarterly Results
27 04 2022	Final Dividend & Audited Results
20 07 2022	Quarterly Results
19 10 2022	Quarterly Results
23 01 2023	Quarterly Results
26 04 2023	Final Dividend & Audited Results
26 07 2023	Quarterly Results
17 10 2023	Quarterly Results
25 01 2024	Quarterly Results
24 04 2024	Final Dividend & Audited Results
23 10 2024	Quarterly Results
23 01 2025	Quarterly Results
23 04 2025	Final Dividend & Audited Results
23 07 2025	Quarterly Results

News

02-DEC-2023

Syngene International concludes acquisition of biologics manufacturing facility

The unit has been acquired effective December 01, 2023 on payment of Rs 395 crore

04:08 PM

05-JUL-2023

Syngene International to acquire Unit 3 biologics manufacturing facility from Stelis Biopharma

The site has the potential for future expansion up to a further 20,000 liters of biologics drug substance manufacturing capacity

09:26 AM

11-AUG-2022

Syngene International incorporates wholly-owned subsidiary

SSSL shall be engaged in Contract Research and Manufacturing Services and Clinical research services

09:38 AM

11-MAR-2025

Syngene International to make additional investment in Syngene USA Inc

The investment is expected to be completed on or before March 31, 2026 or such other date mutually agreed between the parties

12:12 PM

11-MAR-2025

Syngene International’s arm acquires first biologics site in USA

The new site will increase Syngene’s total single-use bioreactor capacity to 50,000L for large molecule discovery, development, and manufacturing services

11:23 AM

12-JUL-2022

Syngene International inks agreement to acquire equity stake up to 26% in AREREPL

To enhance the renewable based power consumption, Syngene International will acquire and maintain 26% stake in AREREPL

04:42 PM

14-JUN-2025

USFDA conducts GCP compliance inspection of Syngene International’s Bengaluru facility

The inspection concluded successfully, with the facility found to be in compliance with the required regulations

10:38 AM

15-JUL-2022

Syngene International signs 10-year biologics manufacturing agreement with Zoetis

Launched in Europe, the UK and Switzerland, the product won ‘Best new companion animal product’ by IHS Markit Connect in 2021

09:38 AM

15-NOV-2022

USFDA conducts inspection at Syngene International’s Biologics facility

The inspection was completed successfully without 483 observations

05:53 PM

18-OCT-2023

Syngene International reports 14% rise in Q2 consolidated net profit

Total consolidated income of the company increased by 18.92% at Rs 931.70 crore for Q2FY24

11:50 AM

21-JUL-2022

Syngene International reports marginal fall in Q1 consolidated net profit

Total consolidated income of the company increased by 8.77% at Rs 660 crore for Q1FY23

05:52 PM

24-FEB-2025

USFDA concludes pre-approval, cGMP inspection at Bengaluru facilities of Syngene International

The inspection conducted from February 10, 2025 to February 20, 2025

10:06 AM

27-APR-2023

Syngene International reports 21% rise in Q4 consolidated net profit

Total consolidated income of the company increased by 31.63% at Rs 1017.20 crore for Q4FY23

01:01 PM

29-AUG-2022

Syngene International incorporates wholly owned subsidiary

The company has acquired is 10 lakh equity shares of Rs 10 each aggregating to Rs 1 crore

12:21 PM